CDMO
Gain Therapeutics is a preclinical biotechnology company focused on developing new medicines for protein misfolding diseases. By identifying and optimizing allosteric binding sites that have never been targeted, Gain Therapeutics unlocks new treatment options for difficult-to-treat disorders characterizied by protein misfolding including lysososmal storage disorders. Due to the company’s unique approach, Gain is one of very few companies that can expedite the identification, validation and design of novel drug compounds to target regulatory allosteric sites on enzymes.
Eric Richman
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.